Clinical Trials
23 trialsSymbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Pfizer
MODIFI-L
Sixth Affiliated Hospital, Sun Yat-sen University
AVR-CHEMO
Arab American University (Palestine)
Neoadjuvant Therapy for Locally Advanced Colon Cancer
Zhejiang University
ROOT
Taproot Health
HDAC Inhibitor Combination With Chemoimmunotherapy in the Neoadjuvant Treatment of pMMR Locally Advanced Colon Cancer
Daping Hospital and the Research Institute of Surgery of the Third Military Medical University
CGA Guided Ultrafractionated RT and First-line Systemic Treatment in Elderly or Frail Patients with MCRC
Fudan University
Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid Tumors
Second Affiliated Hospital of Guangzhou Medical University
The Effect of Unfavorable Histological Features on the Oncological Outcomes of Colon Cancer
Peking Union Medical College Hospital
Observational Study to Evaluate the Use of Targeted Therapies in Metastatic Colorectal Cancer
Grupo Espanol Multidisciplinario del Cancer Digestivo
Improving Food Pleasure and Intake of Oncology Patients Receiving Chemotherapy
University of Florence
Second-look Surgery With or Without Intraperitoneal Chemotherapy in Treating Patients With Recurrent Colorectal Cancer
UNICANCER
JSFOL
Xiangya Hospital of Central South University
1st Line Chemotherapy Alone or With Bevacizumab in Treating Older Patients With Metastatic Colorectal Cancer
Federation Francophone de Cancerologie Digestive
SorCape
University of Florida
CUFOX
University of Leicester
ECHO
National Cancer Center, Korea
CLIMAT
Assistance Publique - Hôpitaux de Paris
CCTDRP
MyGenostics Inc., Beijing
A Pilot Trial of GI-4000 Plus Bevacizumab and Either FOLFOX or FOLFIRI
Georgetown University
First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study
King Faisal Specialist Hospital & Research Center
Outpatient Health Care Program for Older Patients Receiving Chemotherapy for Newly Diagnosed Breast Cancer or Colon Cancer
Case Comprehensive Cancer Center
Fluorouracil With or Without Mitomycin in Treating Patients With Peritoneal Cancer
National Cancer Institute (NCI)